| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 54.550 | 99.740 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 68.676 | 99.829 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 8.492 | 60.877 | 195.249 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -8.492 | 7.799 | -95.420 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -8.492 | 7.309 | -95.420 |
| Employees | - | - | - | - | - | - | - | 1 | 2 | 5 |
Check the financial reports for the company - Oncofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 3.592 | 4.909 | 5.210 |
| Current Assets | - | - | - | - | - | - | - | 2.550 | 10.617 | 31.619 |
| Inventories | - | - | - | - | - | - | - | 2.376 | 5.671 | 22.705 |
| Receivables | - | - | - | - | - | - | - | 0 | 4.121 | 7.052 |
| Cash | - | - | - | - | - | - | - | 174 | 825 | 1.862 |
| Shareholders Funds | - | - | - | - | - | - | - | -8.451 | -1.117 | -96.531 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 14.594 | 16.642 | 133.359 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Oncofarm S.r.l.